These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25648361)

  • 1. Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship.
    Carenco C; Assenat E; Faure S; Duny Y; Danan G; Bismuth M; Herrero A; Jung B; Ursic-Bedoya J; Jaber S; Larrey D; Navarro F; Pageaux GP
    Am J Transplant; 2015 Mar; 15(3):678-86. PubMed ID: 25648361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors.
    Carenco C; Faure S; Herrero A; Assenat E; Duny Y; Danan G; Bismuth M; Chanques G; Ursic-Bedoya J; Jaber S; Larrey D; Navarro F; Pageaux GP
    Liver Int; 2015 Jun; 35(6):1748-55. PubMed ID: 25488375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.
    Shao ZY; Yan LN; Wang WT; Li B; Wen TF; Yang JY; Xu MQ; Zhao JC; Wei YG
    World J Gastroenterol; 2012 Mar; 18(9):991-8. PubMed ID: 22408361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Delayed Prolonged-Release Tacrolimus Initiation in De Novo Hepatitis C Virus-Negative Orthotopic Liver Transplant Recipients: A Single-Center, Single-Arm, Prospective Study.
    Lladó L; González-Castillo A; Fabregat J; Baliellas C; Ramos E; González-Vilatarsana E; Busquets J; Xiol X
    Ann Transplant; 2019 Jan; 24():36-44. PubMed ID: 30655498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome.
    Rodríguez-Perálvarez M; Germani G; Papastergiou V; Tsochatzis E; Thalassinos E; Luong TV; Rolando N; Dhillon AP; Patch D; O'Beirne J; Thorburn D; Burroughs AK
    J Hepatol; 2013 Feb; 58(2):262-70. PubMed ID: 23023010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus exposure after liver transplantation for alcohol-related liver disease: Impact on complications.
    Bardou FN; Guillaud O; Erard-Poinsot D; Chambon-Augoyard C; Thimonier E; Vallin M; Boillot O; Dumortier J
    Transpl Immunol; 2019 Oct; 56():101227. PubMed ID: 31351125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of long-term exposure to tacrolimus on chronic kidney disease after lung transplantation: A retrospective analysis from a single transplantation center.
    Xiong D; Yue B; Ye S; Wang H; Ban L; Chen Y; Lv J; Zhou M; Yin P; Chen J
    Transpl Immunol; 2023 Jun; 78():101810. PubMed ID: 36918103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation.
    Jia JJ; Lin BY; He JJ; Geng L; Kadel D; Wang L; Yu DD; Shen T; Yang Z; Ye YF; Zhou L; Zheng SS
    World J Gastroenterol; 2014 Aug; 20(32):11363-9. PubMed ID: 25170223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the use of Calcineurin inhibitors in liver transplantation.
    de Mare-Bredemeijer EL; Metselaar HJ
    Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative carcinogenicity of tacrolimus
    Liu D; Youssef MM; Grace JA; Sinclair M
    World J Hepatol; 2024 Apr; 16(4):650-660. PubMed ID: 38689747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
    Berenguer M; Aguilera V; San Juan F; Benlloch S; Rubin A; López-Andujar R; Moya A; Pareja E; Montalva E; Yago M; de Juan M; Mir J; Prieto M
    Transplantation; 2010 Dec; 90(11):1204-9. PubMed ID: 21068701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations.
    Varghese J; Reddy MS; Venugopal K; Perumalla R; Narasimhan G; Arikichenin O; Shanmugam V; Shanmugam N; Srinivasan V; Jayanthi V; Rela M
    Indian J Gastroenterol; 2014 May; 33(3):219-25. PubMed ID: 24740447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation.
    Hao JC; Wang WT; Yan LN; Li B; Wen TF; Yang JY; Xu MQ; Zhao JC; Wei YG
    World J Gastroenterol; 2014 Aug; 20(32):11356-62. PubMed ID: 25170222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.
    Forgacs B; Merhav HJ; Lappin J; Mieles L
    Transplant Proc; 2005 May; 37(4):1912-4. PubMed ID: 15919502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.